Deerfield Management Company, L.P. (Series C) Fulgent Genetics, Inc. Transaction History
Deerfield Management Company, L.P. (Series C)
- $5.38 Billion
- Q3 2024
A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 21,690 shares of FLGT stock, worth $375,453. This represents 0.01% of its overall portfolio holdings.
Number of Shares
21,690Holding current value
$375,453% of portfolio
0.01%Shares
3 transactions
Others Institutions Holding FLGT
# of Institutions
201Shares Held
16.1MCall Options Held
2.04MPut Options Held
14K-
Black Rock Inc. New York, NY3.92MShares$67.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.45MShares$25.1 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.27MShares$22 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.11MShares$19.2 Million0.01% of portfolio
-
State Street Corp Boston, MA794KShares$13.7 Million0.0% of portfolio
About Fulgent Genetics, Inc.
- Ticker FLGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 30,265,800
- Market Cap $524M
- Description
- Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...